UniPharma Co., Ltd. (TPEX:6621)
Taiwan · Delayed Price · Currency is TWD 11.75
+0.55 (4.91%)
Jun 12, 2026, 1:34 PM CST
UniPharma Market Cap
UniPharma has a market cap or net worth of 397.61 million as of June 12, 2026. Its market cap has decreased by -22.49% in one year.
Market Cap
397.61M
Enterprise Value
273.22M
Revenue
88.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.75
Market Cap Chart
Since August 18, 2017, UniPharma's market cap has decreased from 679.51M to 397.61M, a decrease of -41.49%. That is a compound annual growth rate of -5.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 413.59M | -4.12% |
| Dec 31, 2025 | 431.34M | -12.27% |
| Dec 31, 2024 | 491.69M | -6.42% |
| Dec 29, 2023 | 525.41M | -4.52% |
| Dec 30, 2022 | 550.27M | 37.73% |
| Dec 30, 2021 | 399.53M | -25.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.46B |
| Winston Medical Supply | 1.17B |
| InnoPharmax | 1.16B |
| Prince Pharmaceutical | 1.15B |
| Excelsior Biopharma | 1.12B |
| DV Biomed | 1.00B |
| Anxo Pharmaceutical | 983.33M |
| Mediera | 882.95M |